Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-01

Clinical Trial Update: Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC [Phase 2]

View source ↗

Summary

Phase 2 randomized trial of alvimopan vs placebo after CRS/HIPEC for ileus was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvimopan (alvimopan)

Snippet

Sponsor: University of California, San Diego | Conditions: Ileus | Phase 2 | Status: TERMINATED | Results posted: 2021-07-01